PhaseBio Pharmaceuticals
(NASDAQ) PHAS
PhaseBio Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$818.00K
Net Income (TTM)
$27.84M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PHAS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PhaseBio Pharmaceuticals
PHAS Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-12%
Net Income Margin
-12%
Return on Equity
0%
Return on Capital
-0%
Return on Assets
-0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$10.83K
Operating Income
$130.42K
EBITDA
$1.66M
Operating Cash Flow
$47.42M
Capital Expenditure
$2.68M
Free Cash Flow
$50.09M
Cash & ST Invst.
$41.80M
Total Debt
$7.84M
PhaseBio Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$208.00K
-98.0%
Gross Profit
$208.00K
-98.0%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
60
N/A
Net Income
$16.78M
+41.5%
EBITDA
$15.95M
+39.2%
Quarterly Fundamentals
Net Cash
$2.43M
-95.4%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$869.00K
-83.8%
Short Term Debt
$4.50M
-23.2%
Return on Assets
-0.22%
N/A
Return on Invested Capital
-0.40%
N/A
Free Cash Flow
$10.47M
+7.7%
Operating Cash Flow
$10.41M
+6.1%